poisar

Stocks · News reference

Abercrombie & Fitch Posts Upbeat Q2 Results, Joins Semtech, Summit Therapeutics And Other Big Stocks Moving Higher On Wednesday

BenzingaAvi Kapoor

U.S. stocks mixed, Nasdaq up 0.1%. Abercrombie & Fitch shares surge 31.6% after beating earnings and raising forecasts. Other top gainers include Kanzhun, Capricor Therapeutics, Semtech Corp, and more.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Zacks Investment ResearchNa

    Urban Outfitters' Strong Retail Segment Supports Growth Momentum

    Urban Outfitters' Retail segment drove growth with 8% revenue increase to $1.39B and 6.2% comparable sales growth in Q2 fiscal 2027. FP Group led brand performance with 10% comp gains, while Urban Outfitters and Anthropologie also showed positive momentum. Management forecasts mid-single-digit comparable growth for Q3, supported by fall demand and regular-price selling.

  2. Zacks Investment ResearchNa

    Gap's Shares Gain 15% on Q2 Earnings Beat & Revised View

    Gap Inc. reported Q2 adjusted EPS of $0.52, beating consensus estimates despite a 2% revenue decline. The Gap brand showed strong 10% comparable sales growth, while Old Navy declined 4% and Athleta fell 12%. Gross margins improved 20 basis points, and the company raised full-year adjusted EPS guidance to $2.35-$2.45, supported by margin expansion and share repurchases.

  3. Zacks Investment ResearchNa

    Abercrombie's Shares Rise 36% on Q2 Earnings Beat on Tariff Refunds

    Abercrombie & Fitch (ANF) delivered strong second-quarter fiscal 2026 results with record net sales of $1.27 billion (up 5% YoY) and EPS of $4.17, beating consensus estimates. The company marked its 15th consecutive quarter of growth, with both Abercrombie and Hollister brands posting record Q2 sales. ANF raised its fiscal 2026 sales-growth outlook to ~5% and operating margin guidance to 14.5-15%, supported by strong cash flow and $177 million in Q2 share repurchases.

  4. Globenewswire IncKaplan Fox & Kilsheimer Llp

    Kaplan Fox is Investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) and Certain of its Officers and Directors for Potential Securities Law Violations

    Law firm Kaplan Fox is investigating Alignment Healthcare (ALHC) for potential securities violations following a whistleblower complaint alleging accounting irregularities and misclassification of operating expenses as capital expenditures. The allegations artificially inflated the company's financial results and Adjusted EBITDA metrics. ALHC stock fell 16.7% on July 8, 2026, following the news.

  5. Zacks Investment ResearchNa

    Understanding Abercrombie (ANF) Reliance on International Revenue

    Abercrombie & Fitch reported Q2 2026 total revenue of $1.27 billion, up 4.8% year-over-year. International markets contributed significantly, with Europe, Middle East and Africa generating $201.99 million (16% of total) and Asia Pacific contributing $44.16 million (3.5% of total). The company exceeded analyst expectations in both regions. ANF holds a Zacks Rank #1 (Strong Buy) rating, with stock gaining 49.1% over the past month and 97% over three months.